8-K: AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer Following Donna Shiroma's Retirement

AVITA Medical has announced the appointment of Nicole Kelsey as Chief Legal and Compliance Officer, succeeding Donna Shiroma who has retired after six years of service.

Summary

• AVITA Medical has appointed Nicole Kelsey as its new Chief Legal and Compliance Officer and Corporate Secretary, effective July 1, 2024.
• This appointment follows the retirement of Donna Shiroma, who served in the same role for six years.
• Ms. Shiroma's retirement was not due to any disagreements with the company.
• Ms. Kelsey brings over two decades of experience in M&A, securities, and governance, with a strong background in building global regulatory and compliance programs.
• Ms. Shiroma will receive a lump sum payment of $453,000, representing one year of her base salary, a prorated bonus of $113,250 for 2024, 12 months of medical, dental and vision insurance premiums, and accelerated vesting of unvested options and RSUs.
• Ms. Shiroma will also provide transition services for one month under a consulting agreement for $40,000, which may be extended.

Sentiment

Score: 7

Explanation: The document reflects a planned transition with a positive outlook on the new appointment. The retirement of the previous officer is handled professionally with a consulting agreement to ensure a smooth handover. There are no indications of any negative issues.

Positives

• The appointment of Nicole Kelsey brings a wealth of experience in legal, compliance, and corporate governance.
• Ms. Kelsey's background includes international M&A, U.S. Securities laws, and multi-jurisdictional corporate governance.
• The transition plan includes a consulting agreement with Ms. Shiroma to ensure a smooth handover.
• Ms. Kelsey's experience in building global regulatory and compliance programs is a positive for the company's growth.

Negatives

• The company is incurring costs associated with Ms. Shiroma's retirement, including a lump sum payment, bonus, insurance premiums, and accelerated vesting of equity.
• There is a cost associated with the one month consulting agreement with Ms. Shiroma.

Risks

• The transition of key personnel could pose a short-term risk to the company's operations.
• The company's future performance is subject to risks and uncertainties as detailed in their annual report.

Future Outlook

The company anticipates continued growth and aims to enhance its legal and compliance strategies to support commercial growth initiatives. The company's future performance is subject to risks and uncertainties as detailed in their annual report.

Management Comments

• Jim Corbett, Chief Executive Officer of AVITA Medical, stated that Nicole Kelsey's international expertise and strategic leadership will enhance the company's legal and compliance strategies and support commercial growth initiatives.
• Jim Corbett expressed gratitude to Donna Shiroma for her expertise and leadership, which have been instrumental to the growth of AVITA Medical.

Industry Context

The appointment of a new Chief Legal and Compliance Officer is a common occurrence in publicly traded companies, especially those undergoing growth and expansion. Ms. Kelsey's experience in the biotechnology and medical technology sectors aligns with AVITA Medical's focus on regenerative medicine.

Comparison to Industry Standards

• The transition of a Chief Legal Officer is a standard process in corporate governance, with companies often providing severance packages and consulting agreements to ensure a smooth handover.
• The compensation package for Ms. Shiroma, including a lump sum payment, bonus, and benefits continuation, is within the typical range for executive departures.
• Ms. Kelsey's background at companies like Amyris, Criteo, and Medtronic demonstrates a strong track record in relevant industries, which is a positive for AVITA Medical.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a new Chief Legal and Compliance Officer positively, given Ms. Kelsey's experience.
• Employees may experience a change in leadership within the legal and compliance department.
• The transition is expected to be smooth with the consulting agreement in place.

Next Steps

• Nicole Kelsey will assume her role as Chief Legal and Compliance Officer and Corporate Secretary.
• Donna Shiroma will provide transition services for one month under a consulting agreement.
• The company will file the Separation Agreement and Consulting Agreement as exhibits to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.

Key Dates

Keywords

Chief Legal Officer, Compliance Officer, Corporate Secretary, Legal, Retirement, Appointment, Governance, M&A, Securities, AVITA Medical